Figure 4: Resistance patterns to antibiotics in patients with HAUTIs from the GPIU study 2003–2013 [29]; BLI: betalactamase inhibitor
Figure 4: Resistance patterns to antibiotics in patients with HAUTIs from the GPIU study 2003–2013 [29]; BLI: betalactamase inhibitor